{"id":"https://openalex.org/W4200217548","doi":"https://doi.org/10.3897/pharmacia.68.e75298","title":"Morpho-functional indicators changes of rats\u2019 myocardium in experimental doxorubicin-induced chronic heart failure and its pharmacological modulation with new 4-amino-1,2,4-triazole derivative","display_name":"Morpho-functional indicators changes of rats\u2019 myocardium in experimental doxorubicin-induced chronic heart failure and its pharmacological modulation with new 4-amino-1,2,4-triazole derivative","alternate_titles":[],"publication_year":2021,"publication_date":"2021-12-10","ids":{"openalex":"https://openalex.org/W4200217548","doi":"https://doi.org/10.3897/pharmacia.68.e75298"},"language":"en","primary_location":{"id":"doi:10.3897/pharmacia.68.e75298","doi":"https://doi.org/10.3897/pharmacia.68.e75298","is_oa":true,"landing_page_url":"https://doi.org/10.3897/pharmacia.68.e75298","pdf_url":null,"source":{"id":"https://openalex.org/S4210231629","display_name":"Pharmacia","issn_l":"0428-0296","issn":["0428-0296","2603-557X"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310321056","host_organization_name":"Pensoft Publishers","host_organization_lineage":["https://openalex.org/P4310321056"],"host_organization_lineage_names":["Pensoft Publishers"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4200217548"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3897/pharmacia.68.e75298","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086025334","display_name":"Pavlo G. Bak","orcid":"https://orcid.org/0000-0001-9165-4939","observed_orcids":["https://orcid.org/0000-0001-9165-4939"]},"institutions":[{"id":"https://openalex.org/I2802984365","display_name":"Zaporizhzhia State Medical and Pharmaceutical University","ror":"https://ror.org/01pc8e529","country_code":"UA","type":"education","lineage":["https://openalex.org/I2802984365"]}],"countries":["UA"],"is_corresponding":false,"raw_author_name":"Pavlo G. Bak","raw_affiliation_strings":["Zaporozhye State Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zaporozhye State Medical University","institution_ids":["https://openalex.org/I2802984365"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084420106","display_name":"Igor F. Belenichev","orcid":"https://orcid.org/0000-0003-1273-5314","observed_orcids":["https://orcid.org/0000-0003-1273-5314"]},"institutions":[{"id":"https://openalex.org/I2802984365","display_name":"Zaporizhzhia State Medical and Pharmaceutical University","ror":"https://ror.org/01pc8e529","country_code":"UA","type":"education","lineage":["https://openalex.org/I2802984365"]}],"countries":["UA"],"is_corresponding":false,"raw_author_name":"Igor F. Belenichev","raw_affiliation_strings":["Zaporozhye State Medical University,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zaporozhye State Medical University,","institution_ids":["https://openalex.org/I2802984365"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020211913","display_name":"\u041b. \u0406. \u041a\u0443\u0447\u0435\u0440\u0435\u043d\u043a\u043e","orcid":"https://orcid.org/0000-0003-2229-0232","observed_orcids":["https://orcid.org/0000-0003-2229-0232"]},"institutions":[{"id":"https://openalex.org/I2802984365","display_name":"Zaporizhzhia State Medical and Pharmaceutical University","ror":"https://ror.org/01pc8e529","country_code":"UA","type":"education","lineage":["https://openalex.org/I2802984365"]}],"countries":["UA"],"is_corresponding":false,"raw_author_name":"Liudmyla I. Kucherenko","raw_affiliation_strings":["Zaporozhye State Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zaporozhye State Medical University","institution_ids":["https://openalex.org/I2802984365"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101145955","display_name":"A. V. Abramov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802984365","display_name":"Zaporizhzhia State Medical and Pharmaceutical University","ror":"https://ror.org/01pc8e529","country_code":"UA","type":"education","lineage":["https://openalex.org/I2802984365"]}],"countries":["UA"],"is_corresponding":false,"raw_author_name":"Andrei V. Abramov","raw_affiliation_strings":["Zaporozhye State Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zaporozhye State Medical University","institution_ids":["https://openalex.org/I2802984365"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008192032","display_name":"\u041e. V. Khromylova","orcid":"https://orcid.org/0000-0002-5274-9676","observed_orcids":["https://orcid.org/0000-0002-5274-9676"]},"institutions":[{"id":"https://openalex.org/I2802984365","display_name":"Zaporizhzhia State Medical and Pharmaceutical University","ror":"https://ror.org/01pc8e529","country_code":"UA","type":"education","lineage":["https://openalex.org/I2802984365"]}],"countries":["UA"],"is_corresponding":false,"raw_author_name":"Olga V. Khromyl\u043eva","raw_affiliation_strings":["Zaporozhye State Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zaporozhye State Medical University","institution_ids":["https://openalex.org/I2802984365"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2802984365"],"apc_list":{"value":100,"currency":"EUR","value_usd":107},"apc_paid":{"value":100,"currency":"EUR","value_usd":107},"fwci":1.1937,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.78211144,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"68","issue":"4","first_page":"919","last_page":"925"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.9585000276565552,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.9585000276565552,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.021900000050663948,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/doxorubicin-induced-cardiotoxicity","display_name":"doxorubicin cardiotoxicity","score":0.902999997138977},{"id":"https://openalex.org/keywords/chronic-heart-failure","display_name":"chronic heart failure","score":0.9860000014305115},{"id":"https://openalex.org/keywords/cardioprotection","display_name":"cardioprotection","score":0.972000002861023},{"id":"https://openalex.org/keywords/cardiomyocyte-nuclei","display_name":"cardiomyocyte nuclei","score":0.8389999866485596},{"id":"https://openalex.org/keywords/nuclear-to-cytoplasmic-ratio","display_name":"nuclear-cytoplasmic ratio","score":0.9739999771118164},{"id":"https://openalex.org/keywords/rna-content","display_name":"RNA content","score":0.7680000066757202},{"id":"https://openalex.org/keywords/metoprolol","display_name":"metoprolol","score":0.8330000042915344},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.9290000200271606}],"concepts":[{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.6549087166786194},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.5681371688842773},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5623320937156677},{"id":"https://openalex.org/C2781280847","wikidata":"https://www.wikidata.org/wiki/Q409468","display_name":"Metoprolol","level":2,"score":0.4958127439022064},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.45916351675987244},{"id":"https://openalex.org/C190062978","wikidata":"https://www.wikidata.org/wiki/Q79899","display_name":"Cytoplasm","level":2,"score":0.42496681213378906},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41499680280685425},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39870157837867737},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39377105236053467},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35639244318008423},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.34950023889541626},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.27329057455062866},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19021305441856384},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.11719521880149841}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3897/pharmacia.68.e75298","doi":"https://doi.org/10.3897/pharmacia.68.e75298","is_oa":true,"landing_page_url":"https://doi.org/10.3897/pharmacia.68.e75298","pdf_url":null,"source":{"id":"https://openalex.org/S4210231629","display_name":"Pharmacia","issn_l":"0428-0296","issn":["0428-0296","2603-557X"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310321056","host_organization_name":"Pensoft Publishers","host_organization_lineage":["https://openalex.org/P4310321056"],"host_organization_lineage_names":["Pensoft Publishers"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacia","raw_type":"journal-article"},{"id":"pmh:10.3897/pharmacia.68.e75298","doi":null,"is_oa":true,"landing_page_url":"https://doi.org/10.3897/pharmacia.68.e75298","pdf_url":null,"source":{"id":"https://openalex.org/S199213172","display_name":"ZooKeys","issn_l":"1313-2970","issn":["1313-2970","1313-2989"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310321056","host_organization_name":"Pensoft Publishers","host_organization_lineage":["https://openalex.org/P4310321056"],"host_organization_lineage_names":["Pensoft Publishers"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacia 68(4): 919-925","raw_type":"Research Article"},{"id":"pmh:oai:doaj.org/article:cb1f9d85946e432685bea639457c2fbf","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/cb1f9d85946e432685bea639457c2fbf","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacia, Vol 68, Iss 4, Pp 919-925 (2021)","raw_type":"article"},{"id":"pmh:oai:zenodo.org:5790576","doi":null,"is_oa":true,"landing_page_url":"https://zenodo.org/record/5790576","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacia 68((4)) 919-925","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.3897/pharmacia.68.e75298","doi":"https://doi.org/10.3897/pharmacia.68.e75298","is_oa":true,"landing_page_url":"https://doi.org/10.3897/pharmacia.68.e75298","pdf_url":null,"source":{"id":"https://openalex.org/S4210231629","display_name":"Pharmacia","issn_l":"0428-0296","issn":["0428-0296","2603-557X"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310321056","host_organization_name":"Pensoft Publishers","host_organization_lineage":["https://openalex.org/P4310321056"],"host_organization_lineage_names":["Pensoft Publishers"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacia","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4200217548.pdf","grobid_xml":"https://content.openalex.org/works/W4200217548.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W2037424126","https://openalex.org/W2051363181","https://openalex.org/W2053387643","https://openalex.org/W2069982201","https://openalex.org/W2076911700","https://openalex.org/W2082191129","https://openalex.org/W2084304742","https://openalex.org/W2103588309","https://openalex.org/W2164047272","https://openalex.org/W2402803556","https://openalex.org/W2412643743","https://openalex.org/W2606264734","https://openalex.org/W2937392638","https://openalex.org/W3062364896","https://openalex.org/W3132494856","https://openalex.org/W3192465150"],"related_works":["https://openalex.org/W7114987474","https://openalex.org/W4317566589","https://openalex.org/W4387796765","https://openalex.org/W2797636914","https://openalex.org/W7214348152","https://openalex.org/W7160215375","https://openalex.org/W2886292169","https://openalex.org/W2400933801","https://openalex.org/W2390149748","https://openalex.org/W2883029481"],"abstract_inverted_index":{"Bromide":[0],"1":[1],"-":[2],"(\u03b2-phenylethyl)-4-amino-1,2,4-triazolium":[3],"(Hypertril)":[4],"has":[5],"the":[6,17,31,44,52,55,59,91,116,120,162,168,176,184,189,197,204,212,221,227,233],"properties":[7],"of":[8,12,20,33,38,47,51,58,86,107,115,119,151,164,166,170,186,193,199,206,217,223,229,236],"a":[9,27,83,136,141,207],"beta-blocker":[10],"and":[11,90,110,180,191,226],"NO-mimetic,":[13],"is":[14,238],"assigned":[15],"to":[16,42,153,158,244],"IV":[18],"class":[19],"toxicity.":[21],"All":[22],"these":[23],"effects":[24],"make":[25],"Hypertril":[26,48,89,152,237],"promising":[28],"drug":[29,93,213],"for":[30],"treatment":[32],"cardiovascular":[34],"diseases.":[35],"The":[36,149],"aim":[37],"this":[39],"paper":[40],"was":[41,70,122],"study":[43],"cardioprotective":[45,209],"action":[46],"in":[49,61,131,140,161,175,183,188,211,231],"terms":[50,216],"effect":[53,210],"on":[54,72,125],"morpho-functional":[56],"parameters":[57],"myocardium":[60,121],"rats":[62,76],"with":[63,155,196],"experimental":[64],"chronic":[65],"heart":[66],"failure":[67],"(CHF).":[68],"CHF":[69,102,156],"modeled":[71],"80":[73],"white":[74],"outbred":[75],"weighing":[77],"190\u2013220g":[78],"by":[79],"administering":[80],"doxorubicin":[81],"at":[82,105],"cumulative":[84],"dose":[85],"15":[87,111],"mg/kg.":[88,112],"reference":[92],"metoprolol":[94],"succinate":[95],"were":[96],"administered":[97],"within":[98],"30":[99],"days":[100],"after":[101],"modeling,":[103],"intragastrically":[104],"doses":[106],"3.5":[108],"mg/kg":[109],"Morphometric":[113],"analysis":[114],"cellular":[117],"structure":[118],"carried":[123],"out":[124],"an":[126,132,159,173,181],"Axioskop":[127],"microscope":[128],"(Zeiss,":[129],"Germany),":[130],"automatic":[133],"mode":[134],"using":[135],"macro":[137],"program":[138],"developed":[139],"specialized":[142],"programming":[143],"environment":[144],"VIDAS-2.5":[145],"(Kontron":[146],"Elektronik,":[147],"Germany).":[148],"administration":[150],"animals":[154],"led":[157],"increase":[160,174,182],"density":[163,222],"nuclei":[165,190],"cardiomyocytes,":[167],"area":[169],"myocardiocyte":[171],"nuclei,":[172],"nuclear":[177],"cytoplasmic":[178],"ratio":[179,235],"concentration":[185],"RNA":[187,230],"cytoplasm":[192],"cardiomyocytes":[194,225],"compared":[195],"group":[198],"untreated":[200],"animals,":[201],"which":[202],"indicated":[203],"presence":[205],"pronounced":[208],"candidate.":[214],"In":[215],"such":[218],"indicators":[219],"as":[220],"surviving":[224],"content":[228],"them,":[232],"nuclear-cytoplasmic":[234],"significantly":[239],"(p":[240],"<":[241],"0.05)":[242],"superior":[243],"metoprolol.":[245]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4200217548","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2021-12-31T00:00:00"}
